Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa

Bulletin of the World Health Organization

Volumn 87, Issue 10, 2009, Pages 754-762

  Herbst, Abraham J ^a   Cooke, Graham S ^a   Bärnighausen, Till ^a   KanyKany, Angelique ^a   Tanser, Frank ^a   Newell, Marie Louise ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE STRUCTURE; DEMOGRAPHIC TREND; DISEASE TREATMENT; HEALTH SERVICES; HUMAN IMMUNODEFICIENCY VIRUS; MEDICINE; MORTALITY RISK; PUBLIC HEALTH; RURAL AREA;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; RURAL AREA;

ADULT; AGE FACTORS; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; CONFIDENCE INTERVALS; FEMALE; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; RURAL POPULATION; SEX DISTRIBUTION; SOUTH AFRICA;

AFRICA; KWAZULU-NATAL; SOUTH AFRICA; SOUTHERN AFRICA; SUB-SAHARAN AFRICA;

EID: 70350039242     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.08.058982     Document Type: Article

References (45)

1. Detels R, Munoz A, McFarlane G, Kingsley LA, Margolick JB, Giorgi J, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA 1998;280:1497-1503 PMID:9809730 doi:10.1001/jama.280.17.1497 (Pubitemid 28507402)
2. Murphy EL, Collier AC, Kalish LA, Assman SF, Para MF, Flanigan TP, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 2001;135:17-26. PMID:11434728 (Pubitemid 32619279)
3. Sendi PP, Bucher HC, Harr T, Craig BA, Schwietert M, Pfluge D, et al. Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study. AIDS 1999;13:1115-1122 PMID:10397543 doi:10.1097/00002030-199906180-00016 (Pubitemid 29361403)
4. Hogg RS, Heath KV, Yip B, Craib KJP, O'Shaughnessy MV, Schechter MT, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998;279:450-454 PMID:9466638 doi:10.1001/ jama.279.6.450 (Pubitemid 28082255)
5. The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration. ART Cohort Collaboration (ART-CC) groups. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006;367:817-824 PMID:16530575 doi:10.1016/S0140-6736(06)68337-2
6. Abbas UL, Anderson RM, Mellors JW. Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings. J Acquir Immune Defic Syndr 2006;41:632-641 PMID:16652038 doi:10.1097/01.qai. 0000194234.31078.bf
7. Blacker J. The impact of AIDS on adult mortality: evidence from national and regional statistics. AIDS 2004;18 Suppl 2;S19-26. PMID:15319740 (Pubitemid 39037466)
8. Joint United Nations Programme on HIV/AIDS. Report on the global AIDS epidemic. Geneva: UNAIDS; 2006.
9. Baggaley RF, Ferguson NM, Garnett GP. The epidemiological impact of antiretroviral use predicted by mathematical models: a review. Emerg Themes Epidemiol 2005;2:9. PMID:16153307 doi:10.1186/1742-7622-2-9
10. Walensky RP, Wood R, Weinstein MC, Martinson NA, Losina E, Fofana MO, et al. Scaling up antiretroviral therapy in South Africa: the impact of speed on survival. J Infect Dis 2008;197:1324-1332 PMID:18422445 doi:10.1086/587184 (Pubitemid 351632764)
11. The Global Fund to Fight AIDS. Tuberculosis and malaria: partners in impact - results report. Geneva: The Global Fund; 2007.
12. Dorrington RE, Johnson LF, Bradshaw D, Daniel T. The demographic impact of HIV/AIDS in South Africa. National and provincial indicators for 2006. Cape Town: Centre for Actuarial Research, South African Medical Research Council, Actuarial Society of South Africa; 2006.
13. Tanser F, Hosegood V, Bärnighausen T, Herbst K, Nyirenda M, Muhwava W, et al. Cohort profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol 2008;37:959-962 doi:10.1093/ije/dym211
14. Solarsh G, Benzler J, Hosegood V, Tanser F, Vanneste A. Hlabisa DSS, South Africa. In: INDEPTH Network, ed. Population, health, and survival at INDEPTH sites. Ottawa: International Development Research Centre; 2002. pp. 213-220
15. Welz T, Hosegood V, Jaffar S, Bätzing-Feigenbaum J, Herbst K, Newell M-L. Continued very high prevalence of HIV infection in rural KwaZulu-Natal, South Africa: a population based longitudinal study. AIDS 2007;21:1467-1472 PMID:17589193 doi:10.1097/QAD.0b013e3280ef6af2 (Pubitemid 46988007)
16. Coleman RL, Wilkinson D. Increasing HIV prevalence in a rural district of South Africa from 1992 through 1995. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:50-53 PMID:9377125
17. Abdool Karim Q, Abdool Karim SS, Singh B, Short R, Ngxongo S. Seroprevalence of HIV infection in rural South Africa. AIDS 1992;6:1535-1539 PMID:1492937 (Pubitemid 23011866)
18. Bärnighausen T, Tanser F, Mbizana C, Gqwede Z, Wallrauch C, Herbst K, et al. Measuring the force of the HIV epidemic in a rural area of South Africa. Presented at: the 15th Conference on Retroviruses and Opportunistic Infections, Boston, MA, USA, 3-6 February 2008.
19. Hosegood V, Vanneste AM, Timaeus IM. Levels and causes of adult mortality in rural South Africa: the impact of AIDS. AIDS 2004;18:663-671 PMID:15090772 doi:10.1097/00002030-200403050-00011 (Pubitemid 38393466)
20. Nyirenda M, Hosegood V, Barnighausen T, Newell ML. Mortality levels and trends by HIV serostatus in rural South Africa. AIDS 2007;21 Suppl 6;S73-9. PMID:18032942 doi:10.1097/01.aids.0000299413.82893.2b (Pubitemid 350158891)
21. Soleman N, Chandramohan D, Shibuya K. Verbal autopsy: current practices and challenges. Bull World Health Organ 2006;84:239-245 PMID:16583084 doi:10.2471/BLT.05.027003 (Pubitemid 43352406)
22. INDEPTH Standardized Verbal Autopsy questionnaire (revised August 2003). Accra, Ghana: INDEPTH Network; 2003. Available from: http://www.indepth- network.org/core-documents/indepthtools.htm [accessed on 5 May 2008].
23. International statistical classification of diseases and related health problems, 10th revision. Geneva: World Health Organization; 1992.
24. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, eds. Global burden of disease and risk factors. Washington, DC: Oxford University Press and The World Bank; 2006.
25. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575-1580 PMID:17084757 doi:10.1016/S0140-6736(06)69573-1 (Pubitemid 44780738)
26. McGehee MA. Mortality. In: Siegel JS, Swanson DA, eds. The methods and materials of demography, 2nd ed. Amsterdam: Elsevier Academic Press; 2004. pp. 265-300.
27. StataCorp. Statistical Software Release 10.0. In: Release 10 ed. College Station, TX: Stata Corporation; 2007.
28. Doherty T, Colvin M. HIV/AIDS. In: Ijumba P, Day C, Ntuli A, eds. South African health review 2003/04. Durban: Health Systems Trust; 2004. p. 206.
29. Joint United Nations Programme on HIV/AIDS. Monitoring the declaration of commitment on HIV/AIDS: guidelines on construction of core indicators. Geneva: UNAIDS; 2003.
30. South Africa, National Department of Health. National antiretroviral treatment guidelines, 1st ed., 2004. Available from: http://www.doh.gov.za/docs/ factsheets/guidelines/artguide04-f.html [accessed on 14 May 2007].
31. Results extracted from the ASSA 2003 AIDS and demographic model of the Actuarial Society of South Africa. 2005. Available from: http://assaaids.eu1. rentasite.co.za/ASSA2003-Model-3165.htm [accessed on 27 July 2009].
32. Murray CJ, Lopez AD, Feehan DM, Peter ST, Yang G. Validation of the symptom pattern method for analyzing verbal autopsy data. PLoS Med 2007;4:e327. PMID:18031196 doi:10.1371/journal.pmed.0040327 (Pubitemid 350220528)
33. Jahn A, Floyd S, Crampin AC, Mwaungulu F, Mvula H, Munthali F, et al. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet 2008; 371:1603-1611 PMID:18468544 doi:10.1016/S0140-6736(08)60693-5 (Pubitemid 351626844)
34. Beck EJ, Vitoria M, Mandalia S, Crowley S, Gilks CF, Souteyrand Y. National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines? AIDS 2006;20:1497-1502 PMID:16847404 doi:10.1097/01.aids.0000237365.18747.13
35. Badri M, Lawn SD, Wood R. Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study. Lancet 2006;368:1254-9. PMID:17027731 doi:10.1016/S0140- 6736(06)69117-69124 (Pubitemid 44508698)
36. Rice BD, Bätzing-Feigenbaum J, Hosegood V, Tanser F, Hill C, Bärnighausen T, et al. Population and antenatal-based HIV prevalence estimates in a high contracepting female population in rural South Africa. BMC Public Health 2007;7:160. PMID:17640354 doi:10.1186/1471-2458-7-160 (Pubitemid 47252358)
37. Bärnighausen T, Tanser F, Gqwede Z, Mbizana C, Herbst K, Newell ML. High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study. AIDS 2008;22:139-144 PMID:18090402 doi:10.1097/QAD.0b013e3282f2ef43 (Pubitemid 350294888)
38. Adjuik M, Smith T, Clark S, Todd J, Garrib A, Kinfu Y, et al. Cause-specific mortality rates in sub-Saharan Africa and Bangladesh. Bull World Health Organ 2006;84:181-188 PMID:16583076 doi:10.2471/BLT.05.026492 (Pubitemid 43352398)
39. Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006;43:27-34. PMID:16878047 doi:10.1097/01. qai.0000233310.90484.16 (Pubitemid 44306484)
40. Monforte A, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, et al. The Data Collection on Adverse Events of Anti-HIV Drugs. (D:A:D) Study Group. HIV-induced immunodeficiency and mortality from AIDS-defining and non- AIDS-defining malignancies. AIDS 2008;22:2143-2153 PMID:18832878 doi:10.1097/QAD.0b013e3283112b77
41. Wunsch G. Dependence and independence of causes of death. In: Caselli G, Vallin J, Wunsch G, eds. Demography: analysis and synthesis: a treatise in population studies. Burlington, MA: Elsevier Academic Press; 2006. pp. 57-60.
42. Bärnighausen T, Bloom DE. Conditional scholarships" for HIV/AIDS health workers: educating and retaining the workforce to provide antiretroviral treatment in sub-Saharan Africa. Soc Sci Med 2009;68:544-51. PMID:19081662 doi:10.1016/j.socscimed.2008.11.009
43. Bärnighausen T, Bloom DE, Humair S. Human resources for treating HIV/AIDS: needs, capacities, and gaps. AIDS Patient Care STDS 2007;21:799-812. PMID:17944556 doi:10.1089/apc.2007.0193
44. Bärnighausen T. Reasons for loss to follow-up in antiretroviral treatment programmes in South Africa. Future HIV Therapy 2008;2:141-145 doi:10.2217/17469600.2.2.141
45. Bärnighausen T. Access to antiretroviral treatment in the developing world: a framework, review and health systems research agenda. Therapy 2007;4:753-766